Transactions In Connection With Share Buyback Programme

2025-04-22 06:01:04

(MENAFN- GlobeNewsWire - Nasdaq)

On 04 December 2024, Tryg A/S (“Tryg”) announced that the Board of Directors had decided to initiate a share buyback programme of up to DKK 2.0 billion. The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the“Safe Harbour Regulation”). The share buyback programme will end no later than 30 June 2025.

Transactions made under the share buyback programme will be announced through Nasdaq Copenhagen on a weekly basis.

The following transactions have been executed in the period 14 April 2025 to 16 April 2025:

	Number of shares	Avg. purchase price, DKK	Transaction value, DKK
14 April 2025	90,000	149.84	13,485,600
15 April 2025	80,000	151.88	12,150,400
16 April 2025	80,000	150.85	12,068,000
Accumulated for the period	250,000		37,704,000
Accumulated under the programme	10,276,787		1,568,072,334

Detailed information on all transactions under the share buyback programme during the period is included in the attached appendix.

Following the above transactions, Tryg owns a total of 10,771,472 treasury shares corresponding to 1.748% of the total share capital.

Contact information:

Gianandrea Roberti, SVP Head of Investor Relations +45 20 18 82 67, ...
Robin Hjelgaard Løfgren, Head of Investor Relations, +45 41 86 25 88, ...
Peter Brondt, Investor Relations Director +45 22 75 89 04, ...

Visit tryg.com

Attachment

Weekly report on share buyback programme 14 April 2025 - 16 April 2025

MENAFN22042025004107003653ID1109457121

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.